These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 3872055

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A comparison of the cardiac and vasodilatory effects of some calcium entry blockers in perfused isolated guinea-pig hearts.
    Boddeke HW, Wilffert B, Heynis JB, van de Haar Keuken V, Jonkman FA, van Zwieten PA.
    Arch Int Pharmacodyn Ther; 1987 Aug; 288(2):175-85. PubMed ID: 3675080
    [Abstract] [Full Text] [Related]

  • 3. Comparative effects of bepridil, diltiazem, nifedipine and verapamil on haemodynamic parameters and myocardial oxygen consumption in anaesthetized dogs.
    Beaughard M, Michelin MT, Tisne-Versailles J, Lamar JC.
    Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):276-96. PubMed ID: 3493742
    [Abstract] [Full Text] [Related]

  • 4. Differential cardiovascular effects of calcium channel blocking agents: potential mechanisms.
    Millard RW, Lathrop DA, Grupp G, Ashraf M, Grupp IL, Schwartz A.
    Am J Cardiol; 1982 Feb 18; 49(3):499-506. PubMed ID: 6277175
    [Abstract] [Full Text] [Related]

  • 5. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
    Millard RW, Grupp G, Grupp IL, DiSalvo J, DePover A, Schwartz A.
    Circ Res; 1983 Feb 18; 52(2 Pt 2):I29-39. PubMed ID: 6831652
    [Abstract] [Full Text] [Related]

  • 6. Calcium antagonists. Mechanisms, therapeutic indications and reservations: a review.
    Opie LH.
    Q J Med; 1984 Feb 18; 53(209):1-16. PubMed ID: 6324268
    [Abstract] [Full Text] [Related]

  • 7. Investigation of the mechanism of negative inotropic activity of some calcium antagonists.
    Boddeke HW, Wilffert B, Heynis JB, van Zwieten PA.
    J Cardiovasc Pharmacol; 1988 Mar 18; 11(3):321-5. PubMed ID: 2452925
    [Abstract] [Full Text] [Related]

  • 8. Differential actions of calcium antagonists on calcium binding to cardiac sarcolemma.
    Pang DC, Sperelakis N.
    Eur J Pharmacol; 1982 Jul 16; 81(3):403-9. PubMed ID: 6981516
    [Abstract] [Full Text] [Related]

  • 9. Comparative electrophysiologic effects of bepridil, verapamil and diltiazem in conscious and anesthetized dogs.
    Kantelip JP, Alatienne M, Talmant JM, Ghyselinck N, Duchêne-Marullaz P.
    Arch Int Pharmacodyn Ther; 1986 Nov 16; 284(1):5-18. PubMed ID: 3493741
    [Abstract] [Full Text] [Related]

  • 10. Differences in cardiovascular profile among calcium antagonists.
    Taira N.
    Am J Cardiol; 1987 Jan 30; 59(3):24B-29B. PubMed ID: 3544789
    [Abstract] [Full Text] [Related]

  • 11. Myocardial and vascular effects of efonidipine in vitro as compared with nifedipine, verapamil and diltiazem.
    Tanaka H, Masumiya H, Sekine T, Sijuku T, Sugahara M, Taniguchi H, Terada M, Saito W, Shigenobu K.
    Gen Pharmacol; 1996 Apr 30; 27(3):451-4. PubMed ID: 8723524
    [Abstract] [Full Text] [Related]

  • 12. Nifedipine, diltiazem, bepridil and verapamil uptakes into cardiac and smooth muscles.
    Pang DC, Sperelakis N.
    Eur J Pharmacol; 1983 Feb 18; 87(2-3):199-207. PubMed ID: 6601581
    [Abstract] [Full Text] [Related]

  • 13. Bepridil hydrochloride alters potential-dependent and receptor-operated calcium channels in vascular smooth muscle of rabbit aorta.
    Flaim SF, Ratz PH, Swigart SC, Gleason MM.
    J Pharmacol Exp Ther; 1985 Jul 18; 234(1):63-71. PubMed ID: 2409274
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological basis for the therapeutic applications of slow-channel blocking drugs.
    Singh BN.
    Angiology; 1982 Aug 18; 33(8):492-515. PubMed ID: 7051905
    [Abstract] [Full Text] [Related]

  • 15. Electrophysiological effects of bepridil and its quaternary derivative CERM 11888 in closed chest anaesthetized dogs: a comparison with verapamil and diltiazem.
    Leboeuf J, Lamar JC, Massingham R, Ponsonnaille J.
    Br J Pharmacol; 1989 Dec 18; 98(4):1351-9. PubMed ID: 2611495
    [Abstract] [Full Text] [Related]

  • 16. Calcium-channel blocking agents.
    Leonard RG, Talbert RL.
    Clin Pharm; 1982 Dec 18; 1(1):17-33. PubMed ID: 6764159
    [Abstract] [Full Text] [Related]

  • 17. Effects of calcium channel blockers on sinoatrial conduction in the isolated and blood-perfused dog atrium.
    Kobayashi M, Shimotori M, Ogiwara Y, Chiba S.
    Arch Int Pharmacodyn Ther; 1986 Jan 18; 279(1):72-82. PubMed ID: 3485962
    [Abstract] [Full Text] [Related]

  • 18. Calcium ions, drug action and the heart--with special reference to calcium antagonist drugs.
    Opie LH.
    Pharmacol Ther; 1984 Jan 18; 25(3):271-95. PubMed ID: 6151199
    [Abstract] [Full Text] [Related]

  • 19. Uptake of calcium antagonistic drugs into muscles as related to their lipid solubilities.
    Pang DC, Sperelakis N.
    Biochem Pharmacol; 1984 Mar 01; 33(5):821-6. PubMed ID: 6608945
    [Abstract] [Full Text] [Related]

  • 20. Comparative effects of bepridil and verapamil on isolated coronary and systemic vascular and cardiac muscle.
    Campbell JK, Marshall RJ, Winslow E.
    Eur J Pharmacol; 1982 Dec 24; 86(2):217-28. PubMed ID: 6984392
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.